I was just looking at their team and noticed that the Lazard MDs they hired a few years back are no longer listed on their website. What’s going on with the team? Does this mean anything for the rest of Rothschild’s US practice?
| +439 | Female bankers doing brand deals on TikTok | 116 | 9h |
| +142 | UBS rolling out Enhanced Clean Desk Policy, bans deal toys | 16 | 3d |
| +100 | Starting FT in a city 3 hours away, dad has progressing Parkinson's. Looking for advice. | 8 | 1d |
| +73 | JULY 2026 CHICAGO BANK RANKINGS | 29 | 8h |
| +64 | Restructuring is paradise (a completely unbiased account) | 6 | 4d |
| +37 | Not Treated Well by Other Interns | 20 | 2d |
| +36 | Handling frustration | 5 | 4d |
| +34 | Taking days off as an intern | 17 | 10h |
| +28 | Thoughts on Intrepid - Houlihan Merger | 10 | 3d |
| +27 | IB TikTok Influencers (wehave2wizards) | 9 | 3d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Based on the most helpful WSO content, Rothschild's RX team has been highlighted as a strong franchise with great exit opportunities and a solid reputation in the restructuring space. However, there are some notable dynamics to consider:
Team Changes: It appears that Rothschild has experienced some turnover in its RX team, including the departure of Lazard MDs who were brought on a few years ago. While the reasons for these departures aren't explicitly detailed, such changes can sometimes reflect shifts in strategy, market conditions, or internal restructuring.
US Practice Impact: Despite these changes, Rothschild's US practice overall is described as rapidly expanding, with a strong culture of retaining talent across levels. The firm is known for its focus on deal volume rather than size, and its RX team continues to be recognized for providing strong exit opportunities.
Comparison to Other EBs: The RX space has seen increased competition from newer boutiques like PJT and Ducera, which have been gaining market share. This competitive environment might contribute to talent movement across firms. Additionally, other EBs like Greenhill and Centerview have their own unique RX dynamics, such as flexible mandates or generalist programs.
While team turnover can raise questions, Rothschild's RX group remains a respected player in the market, and the broader US practice seems to be on solid footing.
Sources: Why You Should Consider Restructuring – Common Misconceptions/Insight on RX Groups, Rothschild NYC Groups, Why You Should Consider Restructuring – Common Misconceptions/Insight on RX Groups, RX Rankings 2022 - Can we please get restructuring rankings for the benefit of students and incoming interns looking to lateral, Rothschild (NYC) Groups 2022
bump
Have a friend working there and have heard about bad gossip culture and a lot of early departures. Curious to hear thoughts?
Soluta quod accusamus aspernatur porro voluptas et commodi. Autem accusantium quisquam sint possimus veritatis ut quos atque. Quia qui et sint laudantium sint vel. Excepturi repellendus qui et provident iusto. Enim veritatis officia reprehenderit qui minus. Sit nihil et omnis voluptates. Non non molestiae quae sed.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...